tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AXSM Stock Latest News

Axsome Therapeutics price target raised to $180 from $150 at Truist
The FlyAxsome Therapeutics price target raised to $180 from $150 at Truist
7d ago
AXSM
Axsome Therapeutics reports Q4 preliminary Auvelity product sales $92.6M
PremiumThe Fly
Axsome Therapeutics reports Q4 preliminary Auvelity product sales $92.6M
7d ago
AXSM
Axsome Therapeutics price target raised to $180 from $150 at Truist
PremiumThe Fly
Axsome Therapeutics price target raised to $180 from $150 at Truist
10d ago
AXSM
Axsome Therapeutics price target raised to $140 from $138 at RBC Capital
PremiumThe Fly
Axsome Therapeutics price target raised to $140 from $138 at RBC Capital
13d ago
AXSM
Top 3 Trending Stocks, According to Analysts – 1/2/2025
PremiumMarket News
Top 3 Trending Stocks, According to Analysts – 1/2/2025
18d ago
AXSM
FTAI
Axsome Therapeutics price target lowered to $122 from $124 at Mizuho
PremiumThe FlyAxsome Therapeutics price target lowered to $122 from $124 at Mizuho
20d ago
AXSM
Axsome Therapeutics price target raised to $124 from $121 at Cantor Fitzgerald
Premium
The Fly
Axsome Therapeutics price target raised to $124 from $121 at Cantor Fitzgerald
20d ago
AXSM
Truist says ‘aggressive’ buying Axsome Therapeutics after AXS-05 ADA data
Premium
The Fly
Truist says ‘aggressive’ buying Axsome Therapeutics after AXS-05 ADA data
20d ago
AXSM
Axsome data ‘mixed’ but sufficient for approval, says H.C. Wainwright
PremiumThe Fly
Axsome data ‘mixed’ but sufficient for approval, says H.C. Wainwright
20d ago
AXSM
Axsome data support Alzheimer’s agitation approval, says Wells Fargo
PremiumThe Fly
Axsome data support Alzheimer’s agitation approval, says Wells Fargo
21d ago
AXSM
3 Best Stocks to Buy Now, 12/31/2024, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 12/31/2024, According to Top Analysts
21d ago
AXSM
NUVL
Morgan Stanley still ‘positively inclined’ on Axsome Therapeutics’ AXS-05
PremiumThe Fly
Morgan Stanley still ‘positively inclined’ on Axsome Therapeutics’ AXS-05
21d ago
AXSM
Axsome mixed agitation data creates ‘most confusion,’ says Leerink
PremiumThe FlyAxsome mixed agitation data creates ‘most confusion,’ says Leerink
21d ago
AXSM
Analysts see buying opportunity as Axsome slips on mixed Alzheimer’s studies
Premium
The Fly
Analysts see buying opportunity as Axsome slips on mixed Alzheimer’s studies
21d ago
AXSM
Axsome Therapeutics price target raised to $138 from $132 at RBC Capital
Premium
The Fly
Axsome Therapeutics price target raised to $138 from $132 at RBC Capital
21d ago
AXSM
Axsome AXS-05 ADA results supportive of approval, says BofA
PremiumThe Fly
Axsome AXS-05 ADA results supportive of approval, says BofA
21d ago
AXSM
Boeing slips after Jeju Air crash, HashiCorp-IBM draws review: Morning Buzz
PremiumThe Fly
Boeing slips after Jeju Air crash, HashiCorp-IBM draws review: Morning Buzz
21d ago
T
BA
Axsome AXS-05 results in ADA ‘positive,’ drug looks ‘approvable,’ says Truist
PremiumThe Fly
Axsome AXS-05 results in ADA ‘positive,’ drug looks ‘approvable,’ says Truist
21d ago
AXSM
Morning Movers: Boeing lower after Jeju Air 737-800 crash in South Korea
PremiumThe Fly
Morning Movers: Boeing lower after Jeju Air 737-800 crash in South Korea
21d ago
BA
VRA
Axsome data ‘should be adequate’ for FDA approval, says Needham
PremiumThe FlyAxsome data ‘should be adequate’ for FDA approval, says Needham
21d ago
AXSM
Axsome falls after one of two Alzheimer’s trials misses primary endpoint
Premium
The Fly
Axsome falls after one of two Alzheimer’s trials misses primary endpoint
21d ago
AXSM
Axsome Therapeutics says ACCORD-2 Phase 3 trial achieves primary endpoint
Premium
The Fly
Axsome Therapeutics says ACCORD-2 Phase 3 trial achieves primary endpoint
21d ago
AXSM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >